Ferritin in autoimmune diseases

被引:180
作者
Zandman-Goddard, Gisele
Shoenfeld, Yehuda [1 ]
机构
[1] Chaim Sheba Med Ctr, Dept Med B, Ctr Autoimmune Dis, Sackler Fac Med, IL-52621 Tel Hashomer, Israel
[2] Wolfson Med Ctr, Dept Med C, Holon, Israel
关键词
ferritin; rheumatoid arthritis; systemic lupus erythematosus; multiple sclerosis; thyroiditis; polymyositis; dermatomyositis;
D O I
10.1016/j.autrev.2007.01.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Iron, an essential element for many important cellular functions in all living organisms, can catalyze the formation of potentially toxic free radicals. Excessive iron is sequestered by ferritin in a nontoxic and readily available form in a cell. Ferritin is composed of 24 subunits of different proportions of two functionally distinct subunits: ferritin H and L. The expression of ferritin is under delicate control and is regulated at both the transcriptional and post-transcriptional levels by iron, cytokines, hormones, and oxidative stress. Mutations in the ferritin gene cause the hereditary hyperferritinemia-cataract syndrome and neuroferritinopathy. Hyperferritinemia is associated with inflammation, infections, and malignancies. While elevated levels of ferritin are characteristic of adult-onset Still's disease and hemophagocytic syndrome, both associated with inflammation, it has scantly been evaluated in other autoimmune diseases. In this review, we describe ferritin structure and function, hyperferritinemia in disease states and in autoimmune diseases. (c) 2007 Elsevier B.V. All tights reserved.
引用
收藏
页码:457 / 463
页数:7
相关论文
共 50 条
  • [41] The role of flavonoids in autoimmune diseases: Therapeutic updates
    Rengasamy, Kannan R. R.
    Khan, Haroon
    Gowrishankar, Shanmugaraj
    Lagoa, Ricardo J. L.
    Mahomoodally, Fawzi M.
    Khan, Ziyad
    Suroowan, Shanoo
    Tewari, Devesh
    Zengin, Gokhan
    Hassan, Sherif T. S.
    Pandian, Shunmugiah Karutha
    PHARMACOLOGY & THERAPEUTICS, 2019, 194 : 107 - 131
  • [42] The role of adenosinergic pathway in human autoimmune diseases
    Dong, Ke
    Gao, Zhao-wei
    Zhang, Hui-zhong
    IMMUNOLOGIC RESEARCH, 2016, 64 (5-6) : 1133 - 1141
  • [43] Immuno- and genetic therapy in autoimmune diseases
    Chernajovsky, Y
    Dreja, H
    Daly, G
    Annenkov, A
    Gould, D
    Adams, G
    Croxford, JL
    Baker, D
    Podhajcer, OL
    Mageed, RA
    GENES AND IMMUNITY, 2000, 1 (05) : 295 - 307
  • [44] Emerging role of air pollution in autoimmune diseases
    Zhao, Chan-Na
    Xu, Zhiwei
    Wu, Guo-Cui
    Mao, Yan-Mei
    Liu, Li-Na
    Qian-Wu
    Dan, Yi-Lin
    Tao, Sha-Sha
    Zhang, Qin
    Sam, Napoleon Bellua
    Fan, Yin-Guang
    Zou, Yan-Feng
    Ye, Dong-Qing
    Pan, Hai-Feng
    AUTOIMMUNITY REVIEWS, 2019, 18 (06) : 607 - 614
  • [45] Exacerbations of autoimmune diseases during pregnancy and postpartum
    Borba, Vania Vieira
    Zandman-Goddard, Gisele
    Shoenfeld, Yehuda
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 33 (06)
  • [46] Immuno- and genetic therapy in autoimmune diseases
    Y Chernajovsky
    H Dreja
    G Daly
    A Annenkov
    D Gould
    G Adams
    JL Croxford
    D Baker
    OL Podhajcer
    RA Mageed
    Genes & Immunity, 2000, 1 : 295 - 307
  • [47] Antibody repertoire analysis in polygenic autoimmune diseases
    Bashford-Rogers, Rachael J. M.
    Smith, Kenneth G. C.
    Thomas, David C.
    IMMUNOLOGY, 2018, 155 (01) : 3 - 17
  • [48] Natural killer cells in inflammatory autoimmune diseases
    Yang, Yuyan
    Day, Jessica
    Souza-Fonseca Guimaraes, Fernando
    Wicks, Ian P.
    Louis, Cynthia
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2021, 10 (02)
  • [49] Microbiome and autoimmune diseases: cause and effect relationship
    Nogueira, Ana Rita
    Shoenfeld, Yehuda
    CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (05) : 471 - 474
  • [50] Treatment of refractory autoimmune diseases with ablative immunotherapy
    Cohen, Y
    Nagler, A
    AUTOIMMUNITY REVIEWS, 2004, 3 (02) : 111 - 119